A Study of Participants With Cerebral Adrenoleukodystrophy (CALD) Treated With Elivaldogene Autotemcel
Clinical trial NCT06224413 · RECRUITING
Trial details
- NCT number
- NCT06224413
- Sponsor
- Genetix Biotherapeutics Inc.
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2024-03-27
- Primary completion
- 2047-12-30
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.